How to Avoid the Corporate FOMO Trap

Would you bet your company's future on a technology your own experts weren't allowed to see? This high-stakes boardroom panic is known as the fear of missing out in business, a psychological trap where leaders prioritize speed over due diligence to stop a competitor from winning. It's the reason billion-dollar retailers can be convinced to ignore their own red flags and skip critical safety checks. When executives stop asking "how does this work?" and start asking "what if our rival gets it first?", they've already lost the battle for strategic clarity.

Corporate FOMO occurs when the dread of a competitor gaining an edge outweighs rational risk assessment. In his book Bad Blood, John Carreyrou details how this psychological pressure paralyzed executives at Walgreens and Safeway during their dealings with the startup Theranos. They weren't just buying a product; they were trying to buy insurance against their rivals. This behavior turns even the most seasoned business leaders into desperate gamblers who ignore evidence to protect a perceived competitive advantage.

This phenomenon isn't limited to a single era or industry. It's a recurring pattern where mature organizations lose their way during an innovation race. Strategic decision making becomes a game of survival rather than a process of growth. Leaders who recognize the symptoms of this trap can stop a catastrophic investment before it destroys their reputation.

Why Competitor Rivalry Triggers Fear of Missing Out in Business

Walgreens executives were famously obsessed with their rival, CVS. They feared that if they didn't sign Elizabeth Holmes, she would walk across the street to their biggest competitor. This fear was so intense that they ignored the warnings of their own lab consultant, Kevin Hunter. Hunter told them that Theranos was likely overstating its capabilities. He wasn't even allowed to see the lab during his visit to Palo Alto, yet leadership felt they couldn't risk CVS winning the deal.

A McKinsey study on strategic decision making found that nearly 50% of executives feel pressure to innovate faster than their internal processes allow. This pressure often leads to "innovation fees" that act as a substitute for genuine technical verification. Walgreens eventually paid $100 million in such fees without ever verifying the tech inside the box. When a rival's potential move dictates your spending, you've handed your strategy to your enemy.

How Strategic Decision Making Fails Under Pressure

Strategic decision making requires a cold, analytical look at the data. However, when corporate FOMO enters the boardroom, facts become secondary to the feeling of urgency. Executives start to believe that moving fast is a valid substitute for moving correctly. At Safeway, CEO Steve Burd fell into this trap by treating Elizabeth Holmes with a rare level of deference. He saw her as a genius who would reinvent the grocery business through a "wellness play."

Burd's belief was so strong that he ignored his own Chief Medical Officer, Dr. Kent Bradley. Bradley discovered that Theranos results were consistently inconsistent compared to traditional labs. Despite this, Safeway spent $350 million on store renovations for clinics that would eventually sit empty. When leaders value a partnership's narrative over its performance data, the entire organization is placed at risk of a total collapse.

Why Walgreens Theranos Deal Blinded Leadership

The Walgreens Theranos deal is now a classic case of due diligence failure driven by competitive panic. The pharmacy giant committed to a rollout while the technology was still an unverified secret. They even signed contracts that forbid them from reverse-engineering the devices they were supposedly vetting. This lack of transparency should have been a non-negotiable deal-breaker for a healthcare company.

Instead, Walgreens allowed Theranos to dictate the terms because they were blinded by the fear of missing out in business. They excluded their own internal experts from meetings when those experts asked too many pointed questions. According to a Gartner survey, 60% of failed corporate partnerships can be traced back to incomplete due diligence. In this case, the due diligence wasn't just incomplete; it was intentionally bypassed to keep the deal moving.

Where Speed Surpasses Logic

Safeway and Walgreens were both struggling with stagnant growth in their core businesses. They saw the partnership as a way to disrupt the market and gain a massive lead. This desperation made them vulnerable to a charismatic founder who promised the impossible. They believed they were being disruptive when they were actually being negligent. When a company's survival feels tied to a single deal, logic is often the first thing to go.

The sunk cost fallacy also played a significant role in these failures. Once Safeway had spent hundreds of millions on renovations, admitting the technology didn't work was politically impossible for leadership. They kept pushing back launch dates rather than facing the reality of the situation. Strategic decision making must include a clear exit strategy for projects that fail to meet technical milestones.

What Smart Executives Do Differently

To protect your organization from these traps, you must build intentional friction into the partnership process. Speed is only an asset if you're actually moving in the right direction. If a potential partner refuses transparency, it isn't a secret advantage; it's a liability. Use these three specific steps to ensure your next innovation play is grounded in reality.

1. Appoint a Professional Dissenter. For every major deal, assign a high-ranking team member the specific job of finding reasons to say no. Their role is to challenge the corporate FOMO by highlighting every unverified claim.

2. Require Third-Party Technical Verification. Never take a vendor's word for their own performance. Require a side-by-side comparison test with an established competitor before committing any capital or public reputation.

3. Create a Hard No-Go Deadline. Establish clear technical milestones that must be met by specific dates. If the partner fails to deliver a working prototype or verifiable data by the deadline, terminate the agreement immediately without exceptions.

Why First Mover Advantage Is Often a Myth

Critics of slow due diligence argue that in some sectors, the first-mover advantage is everything. They believe that being the first to market with a new technology justifies taking massive risks. In the software world, this "move fast and break things" mentality is common and often rewarded. However, this logic is dangerously misapplied in regulated industries like healthcare, finance, or logistics.

When human lives or financial security are involved, breaking things has legal and ethical consequences that can destroy a brand forever. The "first-mover" in the Walgreens Theranos deal was left with a billion-dollar lawsuit and a tarnished legacy. Strategic decision making shouldn't ignore the competition, but it must never be driven by them. A rival's bad decision shouldn't tempt you to make your own.

Leaders who succumb to the fear of missing out in business risk trading their company's integrity for a perceived head start. Rushing a deal to beat a rival often results in inheriting their biggest failures instead of a competitive advantage. Before signing any major partnership, invite an external auditor to verify the vendor’s technical claims independently.